INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 149 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $428,000 | -66.8% | 17,363 | -44.2% | 0.04% | -68.8% |
| Q3 2020 | $1,290,000 | -39.5% | 31,125 | -8.1% | 0.11% | -51.9% |
| Q1 2020 | $2,132,000 | +354.6% | 33,878 | +505.0% | 0.23% | +2230.0% |
| Q2 2018 | $469,000 | -81.7% | 5,600 | -86.6% | 0.01% | -77.8% |
| Q1 2018 | $2,565,000 | -31.2% | 41,700 | +35.4% | 0.04% | -19.6% |
| Q2 2017 | $3,728,000 | +18.0% | 30,800 | +60.4% | 0.06% | -46.2% |
| Q3 2016 | $3,160,000 | +413.0% | 19,200 | +300.0% | 0.10% | +246.7% |
| Q1 2016 | $616,000 | -60.3% | 4,800 | -12.7% | 0.03% | -79.9% |
| Q1 2015 | $1,551,000 | – | 5,500 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |